Shows
Journal of Clinical Oncology (JCO) PodcastRadiotherapy Dose Reduction Is Possible With Induction Chemotherapy for Pediatric Nasopharynx CancerThis JCO Podcast provides observations and commentary on the JCO article, "Treatment of Childhood Nasopharyngeal Carcinoma with Induction Chemotherapy and Concomitant Chemoradiotherapy: Results of the Children’s Oncology Group ARAR0331 Study" by Rodriguez-Galindo et al. My name is Suzanne Wolden, and I am the Director of Pediatric Radiation Oncology at Memorial Sloan Kettering in New York City, USA. My oncologic specialty is Pediatric Radiation Oncology. This important manuscript summarizes the results of Children’s Oncology Group protocol ARAR0331 for childhood nasopharyngeal carcinoma. The study enrolled 111 patients, of whom 75% were male and 47% were African American, with a median age of...2019-10-0109 min
Journal of Clinical Oncology (JCO) PodcastRadiotherapy Dose Reduction Is Possible With Induction Chemotherapy for Pediatric Nasopharynx CancerThis JCO Podcast provides observations and commentary on the JCO article, "Treatment of Childhood Nasopharyngeal Carcinoma with Induction Chemotherapy and Concomitant Chemoradiotherapy: Results of the Children’s Oncology Group ARAR0331 Study" by Rodriguez-Galindo et al. My name is Suzanne Wolden, and I am the Director of Pediatric Radiation Oncology at Memorial Sloan Kettering in New York City, USA. My oncologic specialty is Pediatric Radiation Oncology. This important manuscript summarizes the results of Children’s Oncology Group protocol ARAR0331 for childhood nasopharyngeal carcinoma. The study enrolled 111 patients, of whom 75% were male and 47% were African American, with a median age of...2019-10-0109 min